Cells of extraembryonic mesodermal origin confer human dystrophin in the Mdx model of duchenne muscular dystrophy

Duchenne muscular dystrophy is an X‐linked recessive genetic disease characterized by severe skeletal muscular degeneration. The placenta is considered to be a promising candidate cell source for cellular therapeutics because it contains a large number of cells and heterogenous cell populations with myogenic potentials. We analyzed the myogenic potential of cells obtained from six parts of the placenta, that is, umbilical cord, amniotic epithelium, amniotic mesoderm, chorionic plate, villous chorion, and decidua basalis. In vitro cells derived from amniotic mesoderm, chorionic plate, and villous chorion efficiently transdifferentiate into myotubes. In addition, in vivo implantation of placenta‐derived cells into dystrophic muscles of immunodeficient mdx mice restored sarcolemmal expression of human dystrophin. Differential contribution to myogenesis in this study may be attributed to placental portion‐dependent default cell state. Molecular taxonomic characterization of placenta‐derived maternal and fetal cells in vitro will help determine the feasibility of cell‐based therapy. J. Cell. Physiol. 223:695–702, 2010. © 2010 Wiley‐Liss, Inc.

[1]  S. Kyo,et al.  Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. , 2007, Molecular biology of the cell.

[2]  M. Conconi,et al.  CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. , 2006, International journal of molecular medicine.

[3]  F. Crea,et al.  Myogenic potential of adipose-tissue-derived cells , 2006, Journal of Cell Science.

[4]  J. Bouchard,et al.  Dystrophin Expression in Muscles of Duchenne Muscular Dystrophy Patients After High-Density Injections of Normal Myogenic Cells , 2006, Journal of neuropathology and experimental neurology.

[5]  W. Holzgreve,et al.  Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. , 2005, American journal of obstetrics and gynecology.

[6]  Toshio Miki,et al.  Stem Cell Characteristics of Amniotic Epithelial Cells , 2005, Stem cells.

[7]  M. Hoshino,et al.  Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle Degeneration , 2005, Science.

[8]  T. Kiyono,et al.  Combination of hTERT and bmi-1, E6, or E7 Induces Prolongation of the Life Span of Bone Marrow Stromal Cells from an Elderly Donor without Affecting Their Neurogenic Potential , 2005, Molecular and Cellular Biology.

[9]  C. Dani,et al.  Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse , 2005, The Journal of experimental medicine.

[10]  T. Kiyono,et al.  Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway. , 2005, Molecular biology of the cell.

[11]  T. Kitamura,et al.  Human Placenta‐Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential , 2004, Stem cells.

[12]  S. Hwang,et al.  Skeletal Myogenic Differentiation of Mesenchymal Stem Cells Isolated from Human Umbilical Cord Blood , 2004, Stem cells.

[13]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[14]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[15]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[16]  N. Rosenthal,et al.  The Role of Stem Cells in Skeletal and Cardiac Muscle Repair , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  Dongsheng Duan,et al.  Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy , 2002, Nature Medicine.

[18]  G. Cossu,et al.  Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? , 2000, The Journal of clinical investigation.

[19]  H. Sweeney,et al.  Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. , 1999, The Journal of clinical investigation.

[20]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[21]  J. Ervasti,et al.  Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.

[22]  H. Nishio,et al.  Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy kobe. , 1991, The Journal of clinical investigation.